Shows / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at HCPLive.com/Clinical/Endocrinology. Please direct podcast-related inquiries to PCampbell@MJHLifesciences.com. Editor's note: Episodes…
Episodes
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesNon-Invasive EEG Sensor Aims to Track Glucose in Real Time
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!Non-invasive glucose monitoring is entering a new phase, with an…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesFreeStyle Libre Duo Cleared for Ketone Monitoring
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!Diabetic ketoacidosis remains a leading cause of preventable…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesUltra-rapid insulin, IcoSema advance in type 2 diabetes
Insulin-resistant patients with type 2 diabetes who require high-dose therapy have long lacked a rapid-acting option concentrated enough for compact insulin…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Weekly Insulin Icodec Now Available for Type 2 Diabetes
Once-weekly basal insulin therapy has moved from clinical trial data to pharmacy shelves, offering clinicians a new option for patients who struggle with the…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Tech, Screening, and Care Highlights from ADCES 2026
Advances in diabetes care rarely arrive through a single channel, and the 2026 annual meeting of the Association of Diabetes Care and Education Specialists…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Retatrutide Phase 3 Data Show Major Weight Loss
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!Triple hormone receptor agonism is emerging as a frontier in metabolic…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Evolving Wearable Insulin Delivery Devices - AID, CGM, and More
To begin the episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the rapidly evolving landscape of wearable insulin delivery, focusing on…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Tegoprubart and Freedom from Insulin in Type 1 Diabetes
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!To begin the episode, hosts Diana Isaacs, PharmD, and Natalie Bellini…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Signos and the Science of Weight Loss
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Teplizumab, Stelo, and Inhaled Insulin Afrezza for Pediatric Patients
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
CONNECT, TRANSCEND, and TRIUMPH at ADA 2026
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, shot live at the American Diabetes Association (ADA)…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesThe International Diabetes Federation and Care Access in India, With Amit Gupta, MBBS, DNB
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this special episode, shot live at the American Diabetes Association…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Technology and Treatment in the UK, With Ketan Dhatariya, MD, PhD, MS
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this special episode recorded live at the American Diabetes…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesOmnipod and AID Advancements at Insulet, With Trang Ly, PhD, MBBS
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this special episode recorded live at the American Diabetes…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesThe ADA’s Statement on Diabetes Tech Integration, With Eugene Wright Jr., MD
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this special episode recorded on-site at the American Diabetes…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
FDA Approves Afrezza Inhaled Insulin for Pediatric Patients
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
CKM Systems, Triple Agonists, and a Sensor Scandal Ahead of ADA
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
ADA Scientific Sessions 2026 Preview
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this special in-studio episode of Diabetes Dialogue, cohosts Diana…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Updates for T1D Treatment in Pregnancy and Pediatrics
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, and…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesExpanding GLP-1 Usage Into Type 1 Diabetes With Viral Shah, MD
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode of Diabetes Dialogue, recorded on-site at the American…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesNutrition, Medication, and Treatment in Obesity With Elizabeth Bauer, MD
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode of Diabetes Dialogue, recorded on-site at the American…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesThe Push for Early-Stage T1D Screening and Treatment, With Linda DiMeglio, MD, MPH
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode of Diabetes Dialogue recorded on-site at the American…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Orforglipron Availability, Amazon Pharmacy, and Dosing Considerations
The US Food and Drug Administration approval of orforglipron (Fondayo) in April 2026 may mark a pivotal shift in obesity care—particularly as the first oral…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
The G7 15-Day System and CGM Innovations at Dexcom, With Jessica Castle, MD
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode of Diabetes Dialogue, host Diana Isaacs, PharmD, is…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
FDA Approves Novo Nordisk’s Insulin Icodec-abae (Awiqli) for T2D
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!On March 26, 2026, the US Food and Drug Administration (FDA) approved…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
2026 AACE Guidelines for Type 2 Diabetes
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!On March 17, 2026, the American Association of Clinical Endocrinology…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Orforglipron Receives FDA Approval for Chronic Weight Management
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!The US Food and Drug Administration (FDA) has approved orforglipron…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Q1 2026 Updates from Tandem Diabetes Care, with Laurel Messer, PhD, RN
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!Expanding access to and optimizing use of automated insulin delivery…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
ATTD 2026 Recap
Advances in artificial intelligence, automated insulin delivery, and sensor integration were central to discussions at the 2026 International Conference on…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Orforglipron, Retatrutide, and Other GLP-1 Updates
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Launch of the Zepbound KwikPen
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Implantable Insulin Pumps and Interoperability
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Oral Ozempic and the Risks of Compounding Formulas
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Tech Updates on Twiist, MiniMed Go, and More
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesReviewing the New US Dietary Guidelines with Susan Weiner, MS
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Therapeutic Updates from the ADA 2026 Standards of Care
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Orforglipron, Cagrilintide, and the Libre Assist
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
2026 Technology Updates and American Diabetes Association Standards of Care
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Reacting to Retatrutide and TRIUMPH-4 Topline Data
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Semaglutide Falls Short in Alzheimer Disease, Tirzepatide Shows Promise in T1D
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, breakdown recent trial news from the 2 most popular incretin therapies: semaglutide and…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Updates on Dexcom G7 and Semaglutide Pricing
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, review two major developments in diabetes care: the forthcoming 15-day Dexcom G7…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Oral Semaglutide and SELECT at DTM 2025
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, meet in person at the Diabetes Technology Meeting (DTM) in San Francisco to discuss the…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesBiolinq Shine, Insulin Icodec, and Eli Lilly's Pipeline
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Celebrating 150 Episodes!
In this milestone 150th episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
What's New at Medtronic Diabetes With Bob Vigersky, MD
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Results of ATTAIN-1 and STEP UP Phase 3 Trials
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, an endocrine clinical…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Milestones for MiniMed 780G and Signos CGM for Weight Loss
In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Semaglutide & Tirzepatide Updates at ESC Congress 2025
At ESC 2025, a pair of presentations highlighted the ongoing debate over cardiovascular risk reduction with semaglutide (Ozempic/Wegovy) and tirzepatide…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
FDA Approves Semaglutide (Wegovy) for MASH
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, an endocrine clinical…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
ADCES 2025 Part 3 & Diabetes Tech Updates
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, Diana Isaacs, PharmD, an endocrine clinical pharmacist…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
ADCES 2025 Recap Part 2
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Orforglipron Topline Results & ADCES 2025 Part 1
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, share key…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Tirzepatide and SURPASS-CVOT Topline Results
On July 31, 2025, Eli Lilly and Company announced topline data from the SURPASS‑CVOT trial comparing tirzepatide (Mounjaro) to dulaglutide (Trulicity) in…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Guideline Updates for Diabetes & Pregnancy
Welcome back to Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives!In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
GLP-1s, SGLT2s, and Diabetes Barbie at ENDO 2025
Welcome back to Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives!In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesUpcoming Research on Type 1 Diabetes in Pregnancy with Carol Levy, MD
In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
BELIEVE, GLP-1/GIP Agonists, and CATALYST Results at ADA 2025
In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
American Diabetes Association 2025 Trial Recap - Part 1
In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesThe Diabetes Collective, with Rachael Sood, RN, MSN, APRN
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, recorded during the 85th Scientific Sessions of the American…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesAddressing America's Shortage of Diabetes Care Providers, with Jay Shubrook, DO, & Conan Tu, MD
In this episode of Diabetes Dialogue, recorded live at the 85th Scientific Sessions of the American Diabetes Association (ADA 2025), hosts Diana Isaacs…